Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Common Equity: 2009-2025

Historic Common Equity for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $1.9 billion.

  • BIO-TECHNE's Common Equity fell 8.08% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year decrease of 8.08%. This contributed to the annual value of $1.9 billion for FY2025, which is 7.25% down from last year.
  • Latest data reveals that BIO-TECHNE reported Common Equity of $1.9 billion as of FY2025, which was down 7.25% from $2.1 billion recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Common Equity ranged from a high of $2.1 billion in FY2024 and a low of $1.6 billion during FY2021.
  • For the 3-year period, BIO-TECHNE's Common Equity averaged around $2.0 billion, with its median value being $2.0 billion (2023).
  • Its Common Equity has fluctuated over the past 5 years, first increased by 15.61% in 2023, then decreased by 7.25% in 2025.
  • Yearly analysis of 5 years shows BIO-TECHNE's Common Equity stood at $1.6 billion in 2021, then rose by 8.26% to $1.7 billion in 2022, then grew by 15.61% to $2.0 billion in 2023, then grew by 5.20% to $2.1 billion in 2024, then decreased by 7.25% to $1.9 billion in 2025.